AKBA FY 2017 Earnings — Akebia Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AKBAAkebia Therapeutics, Inc.

$366M

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$178M+11495.0% YoY

Gross Profit

$177M99.7% margin

Operating Income

-$80M-44.9% margin

Net Income

-$77M-43.2% margin

EPS (Diluted)

$-1.77

Cash Flow

Operating Cash Flow

-$56M

Free Cash Flow

-$58M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$364M

Total Liabilities

$245M

Stockholders' Equity

$119M

Cash & Equivalents

$70M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$178M	$2M	+11495.0%
Gross Profit	$177M	-$114M	+255.2%
Operating Income	-$80M	-$136M	+41.4%
Net Income	-$77M	-$136M	+43.3%